We are live on ! Find out more
TECH icon

Bio-Techne

470 hedge funds and large institutions have $13.9B invested in Bio-Techne in 2021 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 151 increasing their positions, 182 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more funds holding in top 10

Funds holding in top 10: 616 (+10)

74% more first-time investments, than exits

New positions opened: 75 | Existing positions closed: 43

28% more call options, than puts

Call options by funds: $21.6M | Put options by funds: $16.8M

22% more capital invested

Capital invested by funds: $11.5B → $13.9B (+$2.47B)

7% more funds holding

Funds holding: 440470 (+30)

2.43% more ownership

Funds ownership: 375.04%377.47% (+2.4%)

17% less repeat investments, than reductions

Existing positions increased: 151 | Existing positions reduced: 182

Holders
470
Holders Change
+30
Holders Change %
+6.82%
% of All Funds
8.25%
Holding in Top 10
16
Holding in Top 10 Change
+10
Holding in Top 10 Change %
+166.67%
% of All Funds
0.28%
New
75
Increased
151
Reduced
182
Closed
43
Calls
$21.6M
Puts
$16.8M
Net Calls
+$4.76M
Net Calls Change
+$6.19M

TECH Hedge Fund Activity: Q1 2021 in Review

470 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2021, worth a combined $13.9B — up 22% from $11.5B a quarter earlier.

Buyers outnumbered sellers: 75 funds opened new TECH positions and 43 closed out — a net gain of 32 holders — while 151 added to existing stakes and 182 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $122M. The largest seller was Atlanta Capital Management, cutting an estimated $92M.

  • 470 institutional investors held Bio-Techne (TECH) as of Q1 2021, up from 440 in Q4 2020.
  • Funds reported $13.9B of Bio-Techne stock for Q1 2021, up 22% quarter-over-quarter.
  • 75 funds opened new Bio-Techne positions in Q1 2021 and 43 closed out, a net change of +32 holders.
  • The largest Bio-Techne buyer in Q1 2021 was Fidelity Investments, an estimated $122M added.
  • The largest Bio-Techne seller in Q1 2021 was Atlanta Capital Management, an estimated $92M sold.

Based on aggregated 13F filings for Q1 2021.